Clinical & translational oncology

• 

  Año 2024, Vol. 26, Número 1

  • Genetic variations in tumor-suppressor miRNA-encoding genes and their target genes: focus on breast cancer development and possible therapeutic strategies

    Y. Chhichholiya, Harsh Vikram Singh, Sandeep Singh, Anjana Munshi

    • Resumen

    págs. 1-15

    

  • Role of miR-424 in the carcinogenesis

    Soudeh Ghafouri-Fard, Arian Askari, Bashdar Mahmud Hussen, Mohammad Taheri, Nader Akbari Dilmaghani

    • Resumen

    págs. 16-38

    

  • The current status and prospect of immunotherapy in colorectal cancer

    Yefei Shu, Song Zheng

    • Resumen

    págs. 39-51

    

  • Carcinogenic roles of MAFG-AS1 in human cancers

    Mohsen Ahmadi, Firouzeh Morshedzadeh, Sayyed Mohammad Hossein Ghaderian, Pegah Mousavi, Leila Habibipour, Maryam Peymani, M.R. Abbaszadegan, Soudeh Ghafouri-Fard

    • Resumen

    págs. 52-68

    

  • Update on the management of elderly patients with colorectal cancer

    Gema Soler González, Javier Sastre Valera, Antonio Viana Alonso, Jorge Aparicio Urtasun, Ignacio García Escobar, M. A. Gómez España, Carmen Guillén Ponce, María José Molina Garrido, Regina Gironés Sarrió

    • Resumen

    págs. 69-84

    

  • Assessing the methodological strengths and limitations of the Spanish Society of Medical Oncology (SEOM) guidelines: a critical appraisal using AGREE II and AGREE-REX tool

    Marilina Santero, Júlia de Mas, Berta Rifà, Inés Clavero, Irene Rexach, X. Bonfill

    • Resumen

    págs. 85-97

    

  • Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology

    Ana Fernández Montes, Elena Élez Fernández, Juan Rafael Haba Rodríguez, David Páez López-Bravo, María José Méndez Vidal, Enriqueta Felip Font, Álvaro Rodríguez Lescure

    • Resumen

    págs. 98-108

    

  • Chordoma: demographics and survival analysis with a focus on racial disparities and the role of surgery, a U.S. population-based study

    Asad Ullah, Guirshney Samarah Kenol, Kue Tylor Lee, Abdul Qahar Khan Yasinzai, Abdul Waheed, Bina Asif, Imran Khan, Hajra Sharif, Jaffar Khan, Saleh Heneidi, Nabin R. Karki, Tamour Khan Tareen

    • Resumen

    págs. 109-118

    

  • Upregulated PPP1R14B is connected to cancer progression and immune infiltration in kidney renal clear cell carcinoma

    Lang Cheng, Junhao Mi, Jiange Zhang, Houbao Huang, Zengnan Mo

    • Resumen

    págs. 119-135

    

  • Comparison of different prediction tools for the risk of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a propensity-matched analysis

    Zhenkai Luo, Binbin Jiao, Hang Zhao, Tao Huang, Yuhao Liu, Haijie Chen, Yunfan Guan, Guan Zhang, Zhaoqiang Jiang

    • Resumen

    págs. 136-146

    

  • Diagnosis of SPECT/CT bone imaging combined with two serum examinations in patients with bone metastases from pulmonary cancer

    Yi Zhou, Chuangui Li, Shasha Jiang, Faliang Niu, Feng Cui, Yusen Zhao, Dong Wei, Hongwei Ma, Yan Li

    • Resumen

    págs. 147-154

    

  • Transarterial embolization followed by staged hepatectomy versus emergency hepatectomy for ruptured HCC: a meta-analysis

    Tianfan Pan, Feng Gao, Xiangzhong Huang, Xinjian Xu

    • Resumen

    págs. 155-170

    

  • Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group

    M. Sánchez Cánovas, David Fernández Garay, Francisco Gómez Martínez, Elena Brozos Vázquez, Miriam Lobo de Mena, Silvia García Adrián, Vilma Emilia Pacheco Barcia, Diego Cacho Lavín, Eva Martínez de Castro, Ana Manuela Martín Fernández de Soignie, Elia Martínez Moreno, Ana Belen Rupérez Blanco, Ignacio García Escobar, Carmen Salvador Coloma, Noel Blaya Boluda, Esperanza Guirao García, Mariano Gambín Arroniz, Andrés Jesús Muñoz Martín

    • Resumen

    págs. 171-177

    

  • Frequency of anticancer drug use at the end of life: a scoping review

    Endre Szigethy, Rosario Dorantes, Miguel Sugrañes, Meisser Madera Anaya, Ivan Solà Arnau, G. Urrutia Cuchi, X. Bonfill

    • Resumen

    págs. 178-189

    

  • Delivery of SIRT1 by cancer-associated adipocyte-derived extracellular vesicles regulates immune response and tumorigenesis of ovarian cancer cells

    Qingling Zheng, Xiuluan Du, Jin Zhang, Yanxiang Liu, Weijia Dong, Xin Dai, Donghua Gu

    • Resumen

    págs. 190-203

    

  • Moderate hypofractionated radiation therapy and pathologic response for soft tissue sarcomas (STS) of limbs and trunk: experience from a tertiary cancer center

    Angel Montero, X. Chen Zhao, Raquel Ciérvide Jurío, Beatriz Álvarez, Alejandro Prado, Mercedes López, Emilio Sánchez Saugar, Ovidio Hernando Requejo, Miguel Ángel de la Casa de Julián, Mariola García Aranda, Jeannette Josefina Valero Albarrán, Rosa Alonso, Pedro Fernández Letón, C. Rubio Rodríguez

    • Resumen

    págs. 204-213

    

  • Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma

    Xiaohong Liu, Dedong Cao, Hui Liu, XiaoKang Ke, Xin Liu, Ximing Xu

    • Resumen

    págs. 214-224

    

  • Clinical characteristics and prognosis analysis of postoperative patients with stage I–III colon cancer based on SEER database

    Fuqiang Zhao, Ying Sun, Jingying Zhao, Jie Ge, Chunlei Zheng, Kepeng Ning

    • Resumen

    págs. 225-230

    

  • Synthesis of the scFv fragment of anti-Frizzled-7 antibody and evaluation of its effects on triple-negative breast cancer in vitro study

    Ebrahim Khodaverdi, Ali Akbar Shabani, Hamid Madanchi, Leila Farahmand

    • Resumen

    págs. 231-238

    

  • Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2− breast cancer in Mexico

    Mariana Molina Jaimes, Antonio Galindo González, H. Verduzco Aguirre, Sergio Bautista Arredondo, Gustavo Reyes Terán, Enrique Soto Pérez de Celis

    • Resumen

    págs. 239-244

    

  • NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway

    Fen Li, Yan Wang, Mengke Wen, Gulibiya Aizezi, Jinrui Yuan, Tongjunnan Zhou, Guqun Shen

    • Resumen

    págs. 245-259